Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC00415, also known as long intergenic non-protein coding RNA 415, is a human long non-coding RNA (lncRNA) located on chromosome 13q12.13[1][5][3]. As inferred from its classification, LINC00415 does not encode a protein product but is instead thought to act at the RNA level, potentially modulating gene expression or chromatin structure[1][5][3]. However, current scientific databases and publications provide only basic annotation and do not ascribe to LINC00415 any well-defined roles in signal transduction, cell proliferation, apoptosis, or disease association such as cancer, inflammation, or other pathologies[1][5][3]. There are currently no reports of therapeutic compounds, biomarkers, or clinical safety concerns specifically tied to LINC00415, and it is not generally regarded as a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 415 (LINC00415).